Results 231 to 240 of about 1,361,764 (281)
Some of the next articles are maybe not open access.
Autologous Bone Marrow Transplantation
Critical Reviews in Clinical Laboratory Sciences, 1995Autologous bone marrow transplantation has become a very popular and successful treatment for many patients with lymphomas and other malignancies. The current indications, pretreatment regimes, and laboratory manipulations are discussed as well as the application of gene transfer to eliminate selected genetic diseases and detect disease relapse.
Leo J. McCarthy +5 more
+7 more sources
Bone Marrow Purging for Autologous Bone Marrow Transplantation
Leukemia & Lymphoma, 1993High dose therapy with the resulting myeloablation rescued by infusion of autologous bone marrow (ABMT) has become a major treatment option for an increasing number of patients with hematologic and solid tumors. ABMT has several potential advantages over allogeneic transplantation.
J G, Gribben, L M, Nadler
openaire +2 more sources
No narcosis for bone marrow harvest in autologous bone marrow transplantation
Blut, 1984A prospective study with mild general analgesia and sedation together with local anesthesia during bone marrow harvest was performed. Thirty-one patients underwent 33 bone marrow collections. Pretreatment consisted of 100 mg meperidine i.m. and 20 mg diazepam i.m. 1 h before start of procedure.
DEVRIES, EGE +5 more
openaire +3 more sources
[Autologous bone marrow transplantation].
Ugeskrift for laeger, 1991Abstract Several malignancies have shown a dose-response relationship. The hematopoietic toxicity of dose escalations is often rescued by bone marrow transplantation. Prolonged disease-free survival can now be expected for patients with lymphoma, Hodgkin's disease, leukemia and breast cancer when high-dose cytotoxic therapy (high dose CT) is followed ...
Joachim Yahalom, Carol S. Portlock
+6 more sources
Autologous Bone Marrow Transplantation
Southern Medical Journal, 1975Bone marrow cells can be aspirated from patients with malignant disorders, stored at low temperatures, and reinfused into the same patient at a later date. In the past, the results of this autologous bone marrow transplantation were equivocal. With the availability of better methods for cryopreservation and more accurate assays for the survival of ...
openaire +2 more sources
Autologous bone marrow transplantation
Current Opinion in Oncology, 1993Very high-dose cytotoxic therapy requiring bone marrow transplantation is the most active treatment for most hematologic malignancies and appears to be the treatment of choice for most patients with these diseases at relapse. Autologous bone marrow transplantation and allogeneic bone marrow transplantation can generally be expected to yield similar ...
openaire +2 more sources
Autologous Bone Marrow Transplantation in Leukemia
1984In patients without HLA-identical donors autologous bone marrow transplantation should be considered as an alternative to conservative treatment of recurrent malignancies. Any patient in complete remission is suitable for an autologous bone marrow transplantation.
B, Netzel, R I, Haas, S, Thierfelder
openaire +2 more sources
Autologous Bone Marrow Transplantation in Hematological Malignancies
American Journal of Clinical Oncology, 1984Autologous bone marrow transplantation (ABMT) has developed considerably in the past 15 years and is now a routine procedure for the consolidation of acute leukemias, non-Hodgkin's lymphomas and Hodgkin's disease. In addition, ABMT has been tested in multiple myeloma (MM) and even considered in highly selected cases of chronic myelocytic leukemia (CML).
openaire +3 more sources
The rationale of autologous bone marrow transplantation.
Bone marrow transplantation, 1991[No abstract available]
MANDELLI, Franco, MELONI, Giovanna
openaire +2 more sources
Autologous Bone Marrow Transplantation for Multiple Myeloma
Hematology/Oncology Clinics of North America, 1992Intensive cytotoxic chemotherapy is capable of more marked tumor cytoreduction including true complete remissions in multiple myeloma. Use of autologous marrow and blood stem cells as well as growth factors has reduced the risk of infection and severe extramedullary toxicities.
S, Jagannath, B, Barlogie
openaire +2 more sources